Hiroaki Hata

Docetaxel plus cisplatin and S-1 versus cisplatin and S-1 in patients with advanced gastric cancer (JCOG1013): an open-label, phase 3, randomised controlled trial

Yasuhide Yamada, Narikazu Boku, Junki Mizusawa et al. · ˜The œLancet. Gastroenterology & hepatology · 2019 · 121 citations

S-1 Versus Cisplatin, Gastrointestinal Oncology, Advanced Gastric Cancer +8

Comparison of Febuxostat and Allopurinol for Hyperuricemia in Cardiac Surgery Patients (NU-FLASH Trial)

Akira Sezai, Masayoshi Soma, Kin‐ichi Nakata et al. · Circulation Journal · 2013 · 120 citations · Full text

Thrombospondin 1 as a novel biological marker of obesity and metabolic syndrome

Yoshiyuki Matsuo, Masashi Tanaka, Hajime Yamakage et al. · Metabolism · 2015 · 98 citations · Full text

Obesity, Metabolic Syndrome, Thrombosis +12

Oral and Parenteral Versus Parenteral Antibiotic Prophylaxis in Elective Laparoscopic Colorectal Surgery (JMTO PREV 07–01)

Hiroaki Hata, Suguru Hasegawa, Akinari Nomura et al. · Annals of Surgery · 2016 · 97 citations

Low-dose continuous infusion of human atrial natriuretic peptide during and after cardiac surgery

Akira Sezai, Motomi Shiono, Yukihiko Orime et al. · The Annals of Thoracic Surgery · 2000 · 96 citations · Full text

Cardiac Surgery, Cardiac Anaesthesia, Cardiothoracic Surgery +6